João Pedro Ferreira Selected Research

João Pedro Ferreira Research Topics

Disease

116	Heart Failure 10/2022 - 10/2013
24	Myocardial Infarction 04/2022 - 02/2017
13	Fibrosis (Cirrhosis) 01/2022 - 01/2018
12	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2020
12	Stroke (Strokes) 10/2021 - 08/2016
10	Hypertension (High Blood Pressure) 11/2021 - 10/2017
9	Left Ventricular Dysfunction 04/2022 - 01/2018
8	Atrial Fibrillation 04/2022 - 08/2016
7	Inflammation (Inflammations) 01/2022 - 01/2019
6	Hyperkalemia 01/2022 - 01/2018
6	Acute Coronary Syndrome 01/2021 - 01/2018
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 05/2017
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
5	Respiratory Sounds (Crackle) 01/2022 - 05/2019
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2022 - 11/2019
4	Hypotension (Low Blood Pressure) 01/2021 - 01/2020
4	Chronic Renal Insufficiency 01/2021 - 11/2016
4	Hemorrhage 01/2021 - 08/2016
4	Diabetes Mellitus 01/2021 - 05/2017
3	Chronic Obstructive Pulmonary Disease (COPD) 10/2022 - 01/2020
3	Prediabetic State (Prediabetes) 08/2022 - 01/2021
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2016
3	Systolic Heart Failure 01/2021 - 01/2018
3	Renal Insufficiency (Renal Failure) 01/2021 - 01/2019
3	Albuminuria 01/2021 - 03/2014
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 01/2017
2	COVID-19 01/2022 - 02/2021
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Obesity 01/2022 - 01/2020
2	Gout 01/2022 - 01/2022
2	Isolated Systolic Hypertension 11/2021 - 07/2021
2	Anemia 01/2021 - 01/2018
2	ST Elevation Myocardial Infarction 02/2020 - 01/2018
2	Hypokalemia 01/2020 - 01/2020
1	Weight Gain 04/2022
1	Weight Loss (Weight Reduction) 04/2022
1	Hyponatremia 04/2022
1	Body Weight (Weight, Body) 04/2022
1	Hypernatremia 04/2022
1	Non-alcoholic Fatty Liver Disease 03/2022
1	Overweight 01/2022
1	Hypertrophy 01/2022
1	Necrosis 01/2022

Drug/Important Bio-Agent (IBA)

28	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2014
28	empagliflozinIBA 10/2022 - 01/2019
21	Spironolactone (Aldactone)FDA LinkGeneric 04/2022 - 03/2014
18	Eplerenone (Inspra)FDA LinkGeneric 04/2022 - 01/2018
17	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022 - 03/2014
15	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 01/2014
10	pro-brain natriuretic peptide (1-76)IBA 10/2022 - 01/2018
10	SodiumIBA 04/2022 - 06/2016
10	CreatinineIBA 02/2021 - 11/2016
9	DiureticsIBA 04/2022 - 10/2013
9	PotassiumIBA 01/2022 - 01/2018
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
8	Natriuretic PeptidesIBA 01/2022 - 12/2016
7	Pharmaceutical PreparationsIBA 03/2022 - 01/2011
7	CollagenIBA 01/2022 - 01/2018
6	AlbuminsIBA 10/2022 - 01/2018
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2020
5	Procollagen Type IIBA 01/2022 - 01/2019
5	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2020
5	alogliptinIBA 07/2021 - 01/2020
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2021 - 01/2019
4	Insulin (Novolin)FDA Link 10/2022 - 04/2019
4	Troponin T (Troponin T1)IBA 10/2022 - 01/2014
4	Collagen Type III (Type III Collagen)IBA 01/2022 - 01/2019
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2021
4	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2022 - 01/2019
4	Antihypertensive Agents (Antihypertensives)IBA 11/2021 - 05/2017
4	TroponinIBA 07/2021 - 01/2014
4	Angiotensin Receptor AntagonistsIBA 06/2021 - 01/2019
4	RivaroxabanIBA 01/2021 - 11/2019
4	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 01/2020
4	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2020 - 06/2016
3	Collagen Type I (Type I Collagen)IBA 01/2022 - 01/2021
3	Uric Acid (Urate)IBA 01/2022 - 10/2020
3	procollagen type I carboxy terminal peptide (PICP)IBA 01/2022 - 01/2019
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021 - 01/2020
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 04/2016
3	Valsartan (Vals)FDA Link 01/2021 - 01/2018
3	AldosteroneIBA 01/2020 - 01/2018
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2022
2	dapagliflozinIBA 11/2021 - 01/2020
2	omega-Chloroacetophenone (Mace)IBA 10/2021 - 02/2021
2	Biological ProductsIBA 02/2021 - 01/2020
2	SymportersIBA 01/2021 - 01/2021
2	Neprilysin (Neutral Endopeptidase)IBA 01/2021 - 01/2020
2	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 04/2015
2	Triglycerides (Triacylglycerol)IBA 11/2020 - 01/2018
2	CholesterolIBA 01/2020 - 01/2019
2	Carvedilol (Coreg)FDA LinkGeneric 01/2020 - 01/2018
2	AnticoagulantsIBA 11/2016 - 08/2016
1	MagnesiumIBA 02/2022
1	C-Reactive ProteinIBA 01/2022
1	Genetic Markers (Genetic Marker)IBA 01/2022
1	LigandsIBA 01/2022
1	Fenofibrate (CiL)FDA LinkGeneric 01/2022

Therapy/Procedure

40	Therapeutics 08/2022 - 10/2013